Gts Securities LLC Direxion Daily S&P Biotech Bea Transaction History

Gts Securities LLC

$2.6 Trillion
Q3 2025

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 08, 2025	BUY	$6.88 - $14.06 $139,863 - $285,825	20,329 New	20,329 $152 Million
Q4 2024 Feb 18, 2025	SELL	$4.98 - $7.44 $242,864 - $362,833	-48,768 Reduced 57.97%	35,362 $256 Million
Q3 2024 Nov 13, 2024	BUY	$5.29 - $7.77 $195,671 - $287,404	36,989 Added 78.46%	84,130 $491,000
Q2 2024 Aug 14, 2024	SELL	$7.1 - $11.03 $325,748 - $506,056	-45,880 Reduced 49.32%	47,141 $345,000
Q1 2024 May 15, 2024	BUY	$5.9 - $10.3 $320,163 - $558,929	54,265 Added 140.02%	93,021 $678,000

Q4 2023 Feb 14, 2024	SELL	$9.2 - $29.48 $74,722 - $239,436	-8,122 Reduced 17.33%	38,756 $375,000
Q3 2023 Nov 15, 2023	BUY	$13.11 - $21.68 $257,126 - $425,209	19,613 Added 71.93%	46,878 $965,000
Q2 2023 Aug 15, 2023	BUY	$11.41 - $21.44 $311,093 - $584,561	27,265 New	27,265 $392 Million

Others Institutions Holding LABD

# of Institutions

3

Shares Held

225K

Call Options Held

4.5K

Put Options Held

0

Chi Advisors LLC New York, NY

225K
Shares

$6.03 Million
2.28% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
100.0% of portfolio

About DIREXION DAILY S&P BIOTECH BEA

Ticker LABD
Sector ETFs
Industry ETFs

More about LABD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.